MRNA Competitors & Alternatives
Compare Moderna Inc with similar stocks in the same industry
Biotechnology
MRNA
Main Stock$221.72
Tradestie Score
53
Market Cap
$10.74B
Revenue Growth
0.0%
Analyst Upside
-37.6%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PFE
Pfizer Inc.
|
$30.52
|
$154.70B | 39.4 | 45 | Compare |
|
VRTX
Vertex Pharmaceuticals Inc
|
$558.88
|
$103.64B | 31.5 | 31 | Compare |
|
REGN
Regeneron Pharmaceuticals Inc
|
$927.89
|
$63.59B | 20.2 | 35 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$165.00
|
$60.38B | 29.3 | 42 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$892.87
|
$46.96B | 31.1 | 51 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$370.33
|
$36.81B | 66.5 | 56 | Compare |
|
INSM
Insmed, Inc.
|
$112.58
|
$31.13B | - | 43 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$88.17
|
$24.57B | - | 66 | Compare |
|
ZM
Zoom Communications, Inc. Class A Common Stock
|
$95.50
|
$24.33B | 9.1 | 49 | Compare |
|
GMAB
Genmab A/S ADS
|
$57.06
|
$19.56B | 45.2 | 36 | Compare |
More MRNA Analysis
Data updated: Nov 01, 2026 | Industry: Biotechnology (SIC 2836)
224 stocks in this industry